China Resources Pharmaceutical GroupSTU:640 +2.97%63 Dividend Payout Ratio is 0.18 as of Dec. 2025, which is 5% below its 10-year median of 0.19. GuruFocus rates STU:640 with a GF Score™ of 63/100 and a GF Value™ of €0.64 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 444 Drug Manufacturers companies, China Resources Pharmaceutical Group ranks better than 79.95% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. China Resources Pharmaceutical Group's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.18.
The historical rank and industry rank for China Resources Pharmaceutical Group's Dividend Payout Ratio or its related term are showing as below:
STU:640'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.19 Max: 0.36
Current: 0.17
During the past 13 years, the highest Dividend Payout Ratio of China Resources Pharmaceutical Group was 0.36. The lowest was 0.17. And the median was 0.19.
STU:640's Dividend Payout Ratio is ranked better than 79.95% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs STU:640: 0.17
During the past 13 years, the highest Trailing Annual Dividend Yield of China Resources Pharmaceutical Group was 5.54%. The lowest was 0.75%. And the median was 2.70%.
During the past 12 months, China Resources Pharmaceutical Group's average Dividends Per Share Growth Rate was -45.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -1.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 9.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of China Resources Pharmaceutical Group was 27.70% per year. The lowest was -1.20% per year. And the median was 7.05% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
China Resources Pharmaceutical Group (STU:640) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
China Resources Pharmaceutical Group Dividend Payout Ratio Related Terms
China Resources Pharmaceutical Group Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Pharmaceutical Group Dividend Payout Ratio Chart
STU:640 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Pharmaceutical Group Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where China Resources Pharmaceutical Group's Dividend Payout Ratio falls into.
China Resources Pharmaceutical Group Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Pharmaceutical Group (STU:640) has a Dividend Payout Ratio of 0.18 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China Resources Pharmaceutical Group and its competitors. This is near median its historical median of 0.19. Over the past decade, China Resources Pharmaceutical Group's Dividend Payout Ratio has ranged from 0.17 to 0.36. According to the industry distribution chart, China Resources Pharmaceutical Group ranks #89 out of 444 companies in the Drug Manufacturers industry, placing it in the top 20%.
Is China Resources Pharmaceutical Group's Dividend Payout Ratio too high?
China Resources Pharmaceutical Group's current Dividend Payout Ratio of 0.18 is near median its 10-year median of 0.19. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.36. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. China Resources Pharmaceutical Group's value of 0.18 is 52% below this industry median. Based on the distribution chart, China Resources Pharmaceutical Group ranks #89 out of 444 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Pharmaceutical Group has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Resources Pharmaceutical Group's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, China Resources Pharmaceutical Group ranks #89 out of 444 companies for Dividend Payout Ratio. This places China Resources Pharmaceutical Group in the top 20% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. China Resources Pharmaceutical Group's value of 0.18 is 52% below this benchmark. Historically, China Resources Pharmaceutical Group's own Dividend Payout Ratio has ranged from 0.17 to 0.36 over the past decade. While the company's 10-year median is 0.19 vs. the industry median of 0.38, China Resources Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Pharmaceutical Group's current Dividend Payout Ratio of 0.18 is 52% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China Resources Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Pharmaceutical Group's current Dividend Payout Ratio is 0.18, which is near median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, China Resources Pharmaceutical Group (STU:640) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.64, compared to a current price of €0.49 — trading 24.1% below its estimated fair value. The current Dividend Payout Ratio is 0.18, which is near median its 10-year median of 0.19 and 52% below the Drug Manufacturers industry median of 0.38. China Resources Pharmaceutical Group's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For China Resources Pharmaceutical Group (STU:640), the current Dividend Payout Ratio is 0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Pharmaceutical Group (STU:640) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Pharmaceutical Group stock appears to be undervalued.
The current stock price of €0.49 is trading 24.1% below its estimated GF Value™ of €0.64.
GuruFocus considers China Resources Pharmaceutical Group to be Modestly Undervalued.
Key valuation signals for STU:640:
Dividend Payout Ratio: 0.18 (near median its 10-year median of 0.19)
GF Value™: €0.64 vs. price of €0.49 (24.1% below fair value)
Industry Position: 52% below the Drug Manufacturers median (#89 of 444)
No single metric tells the full story. See the STU:640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Pharmaceutical Group Business Description
China Resources Pharmaceutical Group Ltd is principally engaged in the manufacture, distribution and retail of pharmaceutical and healthcare products. Specifically, the Group has four reportable segments as follows: Pharmaceutical manufacturing business, Pharmaceutical distribution business, Pharmaceutical retail business , and Other business operations. The company generates majority of its revenue from the Pharmaceutical distribution business.
63GF Score
Get the complete analysis for STU:640
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:640 has been successfully added to your 
